Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
08 mai 2024 08h00 HE
|
Jnana Therapeutics, Inc.
Jnana CEO Joanne Kotz will present a corporate overview at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024 at 2:05 p.m. ET.
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
08 mai 2024 07h30 HE
|
Cytokinetics, Incorporated
Data Support Advancement to Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 Full Data from the Phase 1 Study to be Presented at a...
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
08 mai 2024 07h30 HE
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that CEDAR-HCM (Clinical Evaluation of Dosing with Aficamten to Reduce...
QIAGEN und FBI entwickeln im Bereich Forensik gemeinsam neuen Test für digitale PCR-Plattform QIAcuity
07 mai 2024 16h05 HE
|
QIAGEN N.V.
VENLO, Niederlande, und WASHINGTON, May 07, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute eine Forschungs- und Entwicklungskooperation (Cooperative Research...
Cytokinetics to Hold Annual Meeting of Stockholders
07 mai 2024 16h00 HE
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 15,...
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
07 mai 2024 08h30 HE
|
Inozyme Pharma Inc.
Inozyme reported financial results for the first quarter ended March 31, 2024 and provided business highlights.
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
07 mai 2024 08h30 HE
|
Liquidia Corporation
Liquidia Corporation (NASDAQ: LQDA) announced today it will provide an update on the company at the BofA Securities Health Care Conference 2024.
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
07 mai 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
07 mai 2024 07h00 HE
|
Madrigal Pharmaceuticals, Inc.
On March 14, 2024, received U.S. FDA approval of Rezdiffra™ (resmetirom) for the treatment of patients with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosisIn...
L’écosystème de la biofabrication du Canada propulsé grâce à un nouveau financement
06 mai 2024 12h02 HE
|
Fondation canadienne pour l’innovation
MONTRÉAL, 06 mai 2024 (GLOBE NEWSWIRE) -- La Fondation canadienne pour l’innovation (FCI) aide les établissements du pays à se préparer à faire face aux pandémies et à d’autres urgences...